It was a pleasure to interview Prof. Anat Loewenstein (Tel Aviv Medical Center, Tel Aviv, Israel) on her EURETINA presentation discussing the advantages of home monitoring of age-related macular degeneration, and the results of a study evaluating a new device for home monitoring.
The abstract ‘Functional and anatomical options for home monitoring in the era of long duration treatments for AMD’ was presented at EURETINA 2022, 1–4 September 2022
Questions:
- What are the advantages of home rather than in-office monitoring of age-related macular degeneration? (00:21)
- Could you tell us a little about the home monitoring device you have evaluated? (01:03)
- What were the design and outcome measures of your pilot study? (01:58)
- What were the study findings? (03:38)
- What questions remain unanswered about these devices, and what future studies are planned? (04:24)
Disclosure: Anat Loewenstein is a consultant for Roche, Novartis, NotalVision, Bayer and Beyeonics.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed as a highlight of EURETINA 2022.
